These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38187038)

  • 21. Histone deacetylase inhibitor-mediated sensitization to TRAIL-induced apoptosis in childhood malignancies is not associated with upregulation of TRAIL receptor expression, but with potentiated caspase-8 activation.
    Sonnemann J; Trommer N; Becker S; Wittig S; Grauel D; Palani CD; Beck JF
    Cancer Biol Ther; 2012 Apr; 13(6):417-24. PubMed ID: 22313685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical studies with ONC201/TIC10 and lurbinectedin as a novel combination therapy in small cell lung cancer (SCLC).
    Liguori NR; Sanchez Sevilla Uruchurtu A; Zhang L; Abbas AE; Lee YS; Zhou L; Azzoli CG; El-Deiry WS
    Am J Cancer Res; 2022; 12(2):729-743. PubMed ID: 35261798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.
    LaBonte MJ; Wilson PM; Fazzone W; Groshen S; Lenz HJ; Ladner RD
    BMC Med Genomics; 2009 Nov; 2():67. PubMed ID: 19948057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GABA production induced by imipridones is a targetable and imageable metabolic alteration in diffuse midline gliomas.
    Batsios G; Udutha S; Taglang C; Gillespie AM; Lau B; Ji S; Phoenix T; Mueller S; Venneti S; Koschmann C; Viswanath P
    bioRxiv; 2024 Jun; ():. PubMed ID: 38915617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways.
    Sampson VB; Vetter NS; Kamara DF; Collier AB; Gresh RC; Kolb EA
    PLoS One; 2015; 10(11):e0142704. PubMed ID: 26571493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imipridones inhibit tumor growth and improve survival in an orthotopic liver metastasis mouse model of human uveal melanoma.
    Chattopadhyay C; Roszik J; Bhattacharya R; Alauddin M; Mahmud I; Yadugiri S; Ali MM; Khan FS; Prabhu VV; Lorenzi PL; Wei B; Burton E; Morey RR; Lazcano R; Davies MA; Patel SP; Grimm EA
    Br J Cancer; 2024 Dec; 131(11):1846-1857. PubMed ID: 39394450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic activity of ABT-263 and ONC201/TIC10 against solid tumor cell lines is associated with suppression of anti-apoptotic Mcl-1, BAG3, pAkt, and upregulation of pro-apoptotic Noxa and Bax cleavage during apoptosis.
    Di Cristofano FR; Fong MW; Huntington KE; Carneiro BA; Zhou L; El-Deiry WS
    Am J Cancer Res; 2023; 13(1):307-325. PubMed ID: 36777502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imipridones inhibit tumor growth and improve survival in an orthotopic liver metastasis mouse model of human uveal melanoma.
    Chattopadhyay C; Roszik J; Bhattacharya R; Alauddin M; Mahmud I; Yadugiri S; Ali MM; Khan FS; Prabhu VV; Lorenzi P; Burton E; Morey RR; Lazcano R; Davies MA; Patel SP; Grimm EA
    bioRxiv; 2024 Jan; ():. PubMed ID: 38293232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted inhibition of histone deacetylase leads to suppression of Ewing sarcoma tumor growth through an unappreciated EWS-FLI1/HDAC3/HSP90 signaling axis.
    Ma Y; Baltezor M; Rajewski L; Crow J; Samuel G; Staggs VS; Chastain KM; Toretsky JA; Weir SJ; Godwin AK
    J Mol Med (Berl); 2019 Jul; 97(7):957-972. PubMed ID: 31025088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone deacetylase inhibitors vorinostat and panobinostat induce G1 cell cycle arrest and apoptosis in multidrug resistant sarcoma cell lines.
    Bernhart E; Stuendl N; Kaltenegger H; Windpassinger C; Donohue N; Leithner A; Lohberger B
    Oncotarget; 2017 Sep; 8(44):77254-77267. PubMed ID: 29100385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope?
    Mamdani H; Jalal SI
    Front Cell Dev Biol; 2020; 8():582370. PubMed ID: 33163495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of ONC201 and TLY012 induces selective, synergistic apoptosis in vitro and significantly delays PDAC xenograft growth in vivo.
    Jhaveri AV; Zhou L; Ralff MD; Lee YS; Navaraj A; Carneiro BA; Safran H; Prabhu VV; Ross EA; Lee S; El-Deiry WS
    Cancer Biol Ther; 2021 Dec; 22(10-12):607-618. PubMed ID: 34856854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ONC201 induces cell death in pediatric non-Hodgkin's lymphoma cells.
    Talekar MK; Allen JE; Dicker DT; El-Deiry WS
    Cell Cycle; 2015 Aug; 14(15):2422-8. PubMed ID: 26030065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells.
    Wightman F; Lu HK; Solomon AE; Saleh S; Harman AN; Cunningham AL; Gray L; Churchill M; Cameron PU; Dear AE; Lewin SR
    AIDS; 2013 Nov; 27(18):2853-62. PubMed ID: 24189584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro antitumor effect of sodium butyrate and zoledronic acid combined with traditional chemotherapeutic drugs: a paradigm of synergistic molecular targeting in the treatment of Ewing sarcoma.
    Dos Santos MP; de Farias CB; Roesler R; Brunetto AL; Abujamra AL
    Oncol Rep; 2014 Feb; 31(2):955-68. PubMed ID: 24316794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulators.
    Beider K; Bitner H; Voevoda-Dimenshtein V; Rosenberg E; Sirovsky Y; Magen H; Canaani J; Ostrovsky O; Shilo N; Shimoni A; Abraham M; Weiss L; Milyavsky M; Peled A; Nagler A
    Biochem Pharmacol; 2019 Oct; 168():412-428. PubMed ID: 31325448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignancies.
    Prabhu VV; Talekar MK; Lulla AR; Kline CLB; Zhou L; Hall J; Van den Heuvel APJ; Dicker DT; Babar J; Grupp SA; Garnett MJ; McDermott U; Benes CH; Pu JJ; Claxton DF; Khan N; Oster W; Allen JE; El-Deiry WS
    Cell Cycle; 2018; 17(4):468-478. PubMed ID: 29157092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma.
    Nguyen TTT; Shang E; Schiffgens S; Torrini C; Shu C; Akman HO; Prabhu VV; Allen JE; Westhoff MA; Karpel-Massler G; Siegelin MD
    Clin Cancer Res; 2022 May; 28(9):1881-1895. PubMed ID: 35417530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis.
    Schmidt O; Nehls N; Prexler C; von Heyking K; Groll T; Pardon K; Garcia HD; Hensel T; Gürgen D; Henssen AG; Eggert A; Steiger K; Burdach S; Richter GHS
    J Exp Clin Cancer Res; 2021 Oct; 40(1):322. PubMed ID: 34654445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ONC206, an Imipridone Derivative, Induces Cell Death Through Activation of the Integrated Stress Response in Serous Endometrial Cancer
    Zhang Y; Huang Y; Yin Y; Fan Y; Sun W; Zhao X; Tucker K; Staley A; Paraghamian S; Hawkins G; Prabhu V; Allen JE; Zhou C; Bae-Jump V
    Front Oncol; 2020; 10():577141. PubMed ID: 33194693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.